v3.25.2
Summary of Significant Accounting Policies (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Oct. 11, 2024
USD ($)
Apr. 30, 2020
USD ($)
Apr. 30, 2020
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Policies                  
Net Income (Loss)       $ (100,938,000) $ (37,464,000) $ (167,874,000) $ (105,063,000)    
Accumulated deficit       2,735,736,000   2,735,736,000   $ 2,567,862,000  
Cash, cash equivalents and restricted cash       1,000,021,000 $ 796,798,000 1,000,021,000 $ 796,798,000 945,587,000 $ 642,095,000
Marketable securities       15,975,000   15,975,000   22,689,000  
Short-term Credit Line, outstanding balance       80,338,000   80,338,000   $ 80,362,000  
Collateral amount       150,000,000   150,000,000      
Remaining borrowing capacity       20,000,000   20,000,000      
Convertible Notes                  
Policies                  
Per annum interest rate (as a percent) 2.25%   2.25%            
Percentage of principal amount converted 100.00%                
Convertible Notes Payable $ 287,400,000                
Convertible to shares of common stock 7,500,000 7,411,704              
Proceeds from notes payable $ 100,000                
Line Of Credit-UBS                  
Policies                  
Short-term Credit Line, outstanding balance       80,300,000   80,300,000      
Collateral amount       150,000,000   150,000,000      
Remaining borrowing capacity       $ 20,000,000   $ 20,000,000